New York State Teachers Retirement System Has $8.24 Million Stake in HealthEquity, Inc. $HQY

New York State Teachers Retirement System trimmed its stake in HealthEquity, Inc. (NASDAQ:HQY) by 7.1% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 78,651 shares of the company’s stock after selling 6,024 shares during the period. New York State Teachers Retirement System’s holdings in HealthEquity were worth $8,239,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Mutual Advisors LLC grew its position in HealthEquity by 13.7% in the 2nd quarter. Mutual Advisors LLC now owns 5,880 shares of the company’s stock worth $565,000 after purchasing an additional 708 shares during the last quarter. Sequoia Financial Advisors LLC grew its position in HealthEquity by 78.6% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 29,731 shares of the company’s stock worth $3,115,000 after purchasing an additional 13,086 shares during the last quarter. Index Fund Advisors Inc. acquired a new stake in HealthEquity in the 2nd quarter worth $246,000. Vanguard Personalized Indexing Management LLC boosted its position in shares of HealthEquity by 27.0% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 10,639 shares of the company’s stock valued at $1,115,000 after acquiring an additional 2,263 shares in the last quarter. Finally, US Bancorp DE boosted its position in shares of HealthEquity by 10.9% during the 2nd quarter. US Bancorp DE now owns 20,351 shares of the company’s stock valued at $2,132,000 after acquiring an additional 2,001 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the completion of the transaction, the executive vice president directly owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. The trade was a 3.45% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Delano Ladd sold 6,000 shares of the business’s stock in a transaction dated Friday, September 19th. The stock was sold at an average price of $94.11, for a total transaction of $564,660.00. Following the completion of the transaction, the executive vice president directly owned 79,456 shares of the company’s stock, valued at approximately $7,477,604.16. This represents a 7.02% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is owned by insiders.

Analyst Ratings Changes

Several analysts have recently weighed in on HQY shares. JPMorgan Chase & Co. lifted their target price on shares of HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a research report on Wednesday, September 3rd. Royal Bank Of Canada lifted their target price on shares of HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a research report on Wednesday, September 3rd. Jefferies Financial Group lifted their target price on shares of HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a research report on Wednesday, September 3rd. Raymond James Financial reiterated a “strong-buy” rating and set a $120.00 target price (up from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. Finally, Barrington Research reiterated an “outperform” rating and set a $125.00 target price on shares of HealthEquity in a research report on Friday, August 29th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $121.31.

HealthEquity Price Performance

NASDAQ:HQY opened at $91.46 on Monday. The firm has a market cap of $7.88 billion, a PE ratio of 55.43, a price-to-earnings-growth ratio of 1.32 and a beta of 0.47. HealthEquity, Inc. has a 12 month low of $74.07 and a 12 month high of $116.65. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47. The company’s 50-day moving average price is $91.70 and its two-hundred day moving average price is $94.10.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, September 2nd. The company reported $0.92 EPS for the quarter, meeting analysts’ consensus estimates of $0.92. The firm had revenue of $325.80 million for the quarter, compared to analyst estimates of $320.68 million. HealthEquity had a net margin of 11.49% and a return on equity of 12.04%. HealthEquity has set its FY 2026 guidance at 3.740-3.91 EPS. On average, equities analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.